A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...
The firm expects its $1.25 billion cash runway to cover operating and capital expenses through 2029, including development plans for key assets.